Alcon Surges to 201st in Daily Rankings with $493 Million Trading Volume Despite Stock Price Decline

On May 14, 2025, Alcon's trading volume reached $493 million, marking a 208.46% increase from the previous day. This surge placed Alcon at the 201st position in the daily stock market rankings. However, Alcon's stock price has been on a downward trend, falling 6.45% over the past five days, with a cumulative decline of 9.22%.

Alcon's shares experienced a significant drop after the company revised its 2025 outlook to account for the impact of U.S. tariffs. This revision came as a surprise to investors, leading to a sharp decline in the stock price.

In the first quarter of 2025, Alcon reported core earnings per share (EPS) of 73 cents, a 6.4% decrease from the same period last year. This earnings miss contributed to the downward pressure on the stock price.

Alcon also lowered its 2025 core EPS forecast to a range of $3.05 to $3.15, down from the previous range of $3.15 to $3.25. This adjustment included an estimated $0.10 impact from recent business developments, further dampening investor sentiment.

Despite the earnings miss, Alcon reported first-quarter 2025 net sales of $2.5 billion, which remained unchanged year-over-year on a reported basis but increased by 3% in constant currency. This revenue performance was driven by gains in various segments, including surgical and vision care products.

The company's diluted earnings per share for the first quarter of 2025 were $0.70, reflecting a 40% increase, or 50% on a constant currency basis, compared to the prior year period. This growth was primarily attributed to gains from strategic initiatives and operational improvements.

Alcon's sales for the first quarter of 2025 were $2.5 billion, flat on a reported basis and up 3% on a constant currency basis compared to the same period last year. This performance was impacted by weakness in the U.S. market, which affected overall sales growth.

Looking ahead, Alcon has updated its 2025 sales growth target to 6% to 7%, driven by new product launches and tariff mitigation strategies. This revised outlook aims to address the challenges posed by the current market conditions and regulatory environment.